4
Changes in Ownership
Olema Oncology, Inc. Filed Acc 0001336504-25-000009
Director sold 264,800 shares at an average $29.73 ($7,873,109)
- Director acquired 264,800 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CLARK IAN T Director | 2025-12-19 | Option exercise | +209,690 | $4.41 | $923,894 | 209,690 | D |
| CLARK IAN T Director | 2025-12-19 | Option exercise | +21,520 | $3.61 | $77,687 | 231,210 | D |
| CLARK IAN T Director | 2025-12-19 | Option exercise | +21,520 | $7.84 | $168,717 | 252,730 | D |
| CLARK IAN T Director | 2025-12-19 | Option exercise | +12,070 | $4.08 | $49,246 | 264,800 | D |
| CLARK IAN T Director | 2025-12-19 | Sale | −29,904 | $28.83 | $862,132 | 234,896 | D |
| CLARK IAN T Director | 2025-12-19 | Sale | −193,056 | $29.71 | $5,735,694 | 41,840 | D |
| CLARK IAN T Director | 2025-12-19 | Sale | −41,840 | $30.48 | $1,275,283 | 0 | D |
| Derivatives | |||||||
| CLARK IAN T Director | 2025-12-19 | Option exercise · Stock Option (Right to Buy) | −209,690 | 0 | D | ||
| CLARK IAN T Director | 2025-12-19 | Option exercise · Stock Option (Right to Buy) | −21,520 | 0 | D | ||
| CLARK IAN T Director | 2025-12-19 | Option exercise · Stock Option (Right to Buy) | −21,520 | 0 | D | ||
| CLARK IAN T Director | 2025-12-19 | Option exercise · Stock Option (Right to Buy) | −12,070 | 12,080 | D | ||
| Open-market sales · 264,800 sh · avg $29.73 · $7,873,109 | |||||||
Loading xslF345X05/form4-12242025_021230.xml…